These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 30066297)

  • 1. Vimentin, osteocalcin and osteonectin expression in canine primary bone tumors: diagnostic and prognostic implications.
    Amaral CB; Leite JDS; Fonseca ABM; Ferreira AMR
    Mol Biol Rep; 2018 Oct; 45(5):1289-1296. PubMed ID: 30066297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteocalcin and Osteonectin Expression in Canine Osteosarcoma.
    Wehrle-Martinez AS; Dittmer KE; Aberdein D; Thompson KG
    Vet Pathol; 2016 Jul; 53(4):781-7. PubMed ID: 26926085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of connexins in normal and neoplastic canine bone tissue.
    Sanches DS; Pires CG; Fukumasu H; Cogliati B; Matsuzaki P; Chaible LM; Torres LN; Ferrigno CR; Dagli ML
    Vet Pathol; 2009 Sep; 46(5):846-59. PubMed ID: 19429987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of osteonectin for differential diagnosis of osteogenic bone tumors: an immunohistochemical and in situ hybridization approach.
    Park YK; Yang MH; Park HR
    Skeletal Radiol; 1996 Jan; 25(1):13-7. PubMed ID: 8717113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of alkaline phosphatase staining to differentiate canine osteosarcoma from other vimentin-positive tumors.
    Barger A; Graca R; Bailey K; Messick J; de Lorimier LP; Fan T; Hoffmann W
    Vet Pathol; 2005 Mar; 42(2):161-5. PubMed ID: 15753469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An in vivo/in vitro experimental model system for the study of human osteosarcoma: canine osteosarcoma cells (COS31) which retain osteoblastic and metastatic properties in nude mice.
    Shoieb AM; Hahn KA; Barnhill MA
    In Vivo; 1998; 12(5):463-72. PubMed ID: 9827352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteonectin in osteosarcomas: a marker for differential diagnosis and/or prognosis?
    Wuisman P; Roessner A; Bosse A; Ueda Y; Winkelmann W; Enneking WF
    Ann Oncol; 1992 Apr; 3 Suppl 2():S33-5. PubMed ID: 1622861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteocalcin and osteonectin immunoreactivity in extraskeletal osteosarcoma: a study of 28 cases.
    Fanburg-Smith JC; Bratthauer GL; Miettinen M
    Hum Pathol; 1999 Jan; 30(1):32-8. PubMed ID: 9923924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of immunohistochemical cyclo-oxygenase-2 (COX-2) and osteocalcin in differentiating between osteoblastomas and osteosarcomas.
    El-Badawi ZH; Muhammad EM; Noaman HH
    Malays J Pathol; 2012 Jun; 34(1):15-23. PubMed ID: 22870593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
    Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
    BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 expression in canine appendicular osteosarcomas.
    Mullins MN; Lana SE; Dernell WS; Ogilvie GK; Withrow SJ; Ehrhart EJ
    J Vet Intern Med; 2004; 18(6):859-65. PubMed ID: 15638270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of osteonectin for differential diagnosis of bone tumors. An immunohistochemical approach.
    Bosse A; Vollmer E; Böcker W; Roessner A; Wuisman P; Jones D; Fisher LW
    Pathol Res Pract; 1990 Oct; 186(5):651-7. PubMed ID: 2287591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of gene expression of prostaglandin EP4 receptor in canine osteosarcoma.
    Musser ML; Viall AK; Phillips RL; Hostetter JM; Johannes CM
    Can J Vet Res; 2021 Jan; 85(1):68-71. PubMed ID: 33390656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical localization of bone Gla protein and osteonectin in normal human bone and cartilage tissues, and in osteosarcomas and chondrosarcomas].
    Chiba H; Matsuyama T
    Nihon Seikeigeka Gakkai Zasshi; 1993 May; 67(5):463-72. PubMed ID: 8336066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of alkaline phosphatase and runx2 to distinguish osteosarcoma from other common malignant primary bone tumors in dogs.
    Barger A; Baker K; Driskell E; Sander W; Roady P; Berry M; Schnelle A; Fan TM
    Vet Pathol; 2022 May; 59(3):427-432. PubMed ID: 35253545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipotential osteosarcoma with various mesenchymal differentiations in a young dog.
    Hoenerhoff MJ; Kiupel M; Rosenstein D; Pool RR
    Vet Pathol; 2004 May; 41(3):264-8. PubMed ID: 15133175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblastic osteosarcoma with epithelioid and squamous differentiation in a dog.
    Jenkins TL; Agnew D; Rissi DR
    J Vet Diagn Invest; 2018 Jul; 30(4):593-597. PubMed ID: 29629646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The utility of SATB2 immunohistochemical expression in distinguishing between osteosarcomas and their malignant bone tumor mimickers, such as Ewing sarcomas and chondrosarcomas.
    Machado I; Navarro S; Picci P; Llombart-Bosch A
    Pathol Res Pract; 2016 Sep; 212(9):811-6. PubMed ID: 27465835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive biomarkers of canine osteosarcoma.
    Selvarajah GT; Kirpensteijn J
    Vet J; 2010 Jul; 185(1):28-35. PubMed ID: 20493743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological relevance of tumour grading in canine osteosarcoma.
    Loukopoulos P; Robinson WF
    J Comp Pathol; 2007 Jan; 136(1):65-73. PubMed ID: 17270206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.